Skip Nav Destination
1-17 of 17
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations
Benjamin Djulbegovic, MD, Tea Reljic, MPH, Shira Elqayam, PhD, Adam Cuker, MD MS, Iztok Hozo, PhD, Qi Zhou, PhD, Shelly-Anne Li, PhDc), Paul Alexander, PhD, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Holger Schünemann, MD, Gordon Guyatt, MD
Blood (2018) 132 (Supplement 1): 4707.
Blood (2018) 132 (Supplement 1): 4761.
The IMWG Frailty Score and Age Can be More Effective Than Clinical Judgement in the Selection of Elderly Patients with Newly Diagnosed Multiple Myeloma Who Can Benefit from an Intensive Treatment Approach with High Dose Melphalan and Autologous Stem Cell Transplantation
Angelo Belotti, MD, Rossella Ribolla, Valeria Cancelli, MD, Nicola Bianchetti, Claudia Crippa, MD, Samantha Ferrari, MD, Chiara Bottelli, MD, Chiara Cattaneo, MD, Vincenza Orlando, PharmD, Marco Chiarini, Luigi Grazioli, MD, Giuseppe Rossi
Blood (2018) 132 (Supplement 1): 2151.
The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines
Shelly-Anne Li, PhD, Paul Alexander, PhD, Tea Reljic, MPH, Adam Cuker, MD MS, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Gordon Guyatt, MD, Holger Schünemann, MD, Benjamin Djulbegovic, MD
Blood (2018) 132 (Supplement 1): 2237.
Andrea J. Lee, BS, Elizabeth R. Lyden, MS, Lakshmi Manogna Chintalacheruvu, MD, Thuy Thi Koll, MD, Lori J. Maness, MD, Krishna Gundabolu, MBBS, Vijaya R. Bhatt, MD
Blood (2017) 130 (Supplement 1): 5659.
Predictive Tool to Support Decision-Making about Management of Conflicts of Interest for Guideline Development: Derivation and Validation
Mak Djulbegovic, Stephanie Jaffe, Tea Reljic, Jason Beckstead, Adam Cuker, MD MS, Rob Kunkle, Benjamin Djulbegovic, MD
Blood (2017) 130 (Supplement 1): 4661.
Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy?
Elisavet Chatzilari, Panagiotis Baliakas, Aliki Xochelli, Anastasios Maronidis, Anna Vardi, Mattias Mattsson, Karin Larsson, Vassiliki Douka, Michail Iskas, MD, George Karavalakis, Apostolia Papalexandri, Carsten Niemann, Marco Montillo, Achilles Anagnostopoulos, David Oscier, Sarka Pospisilova, Frederic Davi, MD PhD, Niki Stavroyianni, Paolo Ghia, Anastasia Hadzidimitriou, Richard Rosenquist, Spiros Nikolopoulos, Kostas Stamatopoulos, Yannis Kompatsiaris
Blood (2015) 126 (23): 2921.
Oncology Providers Ability to Prognosticate Patient Outcomes: An Analysis of the Survey on Provider Assessment of Risk (SPAR) Study
Sarah A. Buckley, MD, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS
Blood (2015) 126 (23): 5635.
Electronic Hematology Consultations at Veterans Affairs (VA) Connecticut: Analysis of Effects on Patient Care, and Provider and Patient Satisfaction
Blood (2014) 124 (21): 4857.
Comparison of Proposed NIH Response Criteria with Clinician-Reported Changes in Organ-Specific and Overall Response
Jeanne Palmer, MD, Stephanie J. Lee, MD, MPH, Xiaoyu Chai, MS, Barry Storer, PhD, Joseph Pidala, MD, MS, Corey S. Cutler, MD, MPH, FRCPC, Mukta Arora, MD, Mary E.D. Flowers, MD, Steven Z. Pavletic, MD, Georgia B. Vogelsang, MD, Yoshihiro Inamoto, MD, Madan Jagasia, MD, MS, Chen George, MD, Paul J. Martin, MD
Blood (2011) 118 (21): 1978.
Readiness for Transition From Pediatric Sickle Cell Care: Exploratory Analyses of Domains of Readiness and Total Scores
Wally R. Smith, MD, Virginia Smith, ANP, Kamar Godder, MD, MPH, India Sisler, MD, Robbie Casper, PNP, Shirley Johnson, LSW, Wanda Brice, LCSW, Matthew Bitsko, Ph.D, LCP, April Engram, Alma Morgan
Blood (2010) 116 (21): 2576.
Detection of ERG and MN1 Gene Expression in Adult Patients with De Novo Acute myeloid Leukemia(AML) by Real-Time Quantitative Polymerase Chain Reaction and Its Clinical Significance.
Blood (2009) 114 (22): 4706.
A Comprehensive Geriatric Assessment Is More Effective Than Clinical Judgement to Prospectively Identify Elderly Patients with Diffuse Large Cell Lymphoma Who Can Tolerate Full-Dose Anthracyclin-Based Treatment and Achieve the Same Outcome as Young Patients.
Alessandra Tucci, MD, Chiara Bottelli, MD, Samantha Ferrari, MD, Erika Borlenghi, MD, Monica Drera, MD, Giuseppe Rossi, MD
Blood (2007) 110 (11): 3441.
Evaluation of Clinical Judgement at Initiation of AML-Therapy in Elderly Patients - A Prospective Randomized Trial.
Ulrich S. Schuler, Mathias Hanel, Heinrich Bodenstein, Hermann Einsele, Karl-Heinz Pflueger, Norbert Schmitz, Thomas Wagner, Hannes Wandt, Regina Herbst, Ulrich Kaiser, Gerhard Ehninger
Blood (2007) 110 (11): 2863.
Blood (2005) 106 (11): 5572.
Prospective Validation of the FLIPI: Baseline Distribution and Correlates in Newly Diagnosed Follicular Lymphoma (FL) Patients from the US: First Report of the National LymphoCare Study.
Brian K. Link, James R. Cerhan, Hildy Dillon, Charles M. Farber, Susan Feliciano, Jonathan W. Friedberg, John Hainsworth, Ron Steis, Julie M. Vose, Andrew D. Zelenetz
Blood (2005) 106 (11): 1000.
Complications of Central Venous Catheters in Patients with Hematologic Malignancy: Analysis of Risk Factors.
Annamaria Nosari, MD, Guido Nador, MD, Andrea de Gasperi, MD, Nichelatti Michele, PhD, Anghilieri Michela, MD, Cozzi Paola, MD, Mancini Valentina, MD, Luchesini Camilla, MD, Ricci Francesca, MD, Ciapanna Dennis, MD, Ravelli Erica, MD, Cantoni Silvia, MD, Morra Enrica, MD.
Blood (2004) 104 (11): 4520.